Product Information
ADZENYS XR-ODT 3.1 MG TABLET is a brand product labeled by Neos Therapeutics Brands, LLC, priced at $19.2704 per EA under NDC 70165000530. Its NADAC has been published 458 times since Sep 20, 2017.
Strength
3.1 mg/1
Manufacturer
Neos Therapeutics Brands, LLCNDC
70165000530
Classification
Brand
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
AMPHETAMINEApproval Type
New Drug (NDA)
FDA Application
NDA204326On Market Since
2/16/2016
Pharmacological Classes
Price Statistics
The NADAC for ADZENYS XR-ODT 3.1 MG TABLET has been published 458 times since Sep 20, 2017, and over the history we have for it it has risen 105.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $19.2704 per EA |
|---|---|
| All-time high | $19.3843 (Mar 11, 2026) |
| All-time low | $9.3844 (Sep 20, 2017) |
| 52-week high | $19.3843 |
| 52-week low | $16.7224 |
| Median price | $14.0004 |
| Average price | $13.8989 |
| Largest weekly change | +14.9% (Aug 13, 2025) |
| Weeks tracked | 458 |
| Tracking since | Sep 20, 2017 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Amphetamine market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of ADZENYS XR-ODT 3.1 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ADZENYS XR-ODT 3.1 MG TABLET, manufactured by Neos Therapeutics Brands, LLC, is $19.2704 per EA (NDC 70165000530), effective Jun 24, 2026.
How has the price of ADZENYS XR-ODT 3.1 MG TABLET changed over time?
Over the history we have for it, the NADAC for ADZENYS XR-ODT 3.1 MG TABLET has risen 105.3%. It has been tracked across 458 weekly CMS publications since Sep 20, 2017.
What are the highest and lowest recorded NADAC prices for ADZENYS XR-ODT 3.1 MG TABLET?
Since Sep 20, 2017, the NADAC for ADZENYS XR-ODT 3.1 MG TABLET has ranged from a low of $9.3844 (Sep 20, 2017) to a high of $19.3843 (Mar 11, 2026), with a median of $14.0004 per EA.
Are there cheaper alternatives to ADZENYS XR-ODT 3.1 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ADZENYS XR-ODT 3.1 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures ADZENYS XR-ODT 3.1 MG TABLET?
ADZENYS XR-ODT 3.1 MG TABLET (NDC 70165000530) is labeled by Neos Therapeutics Brands, LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification